SCYNEXIS Inc — Cash Flow (NASDAQ:SCYX) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities 49.35 M54.56 M79.88 M60.16 M24.01 M 33.59 M Cash from investing activities 6.47 M1.17 M27.39 M34.88 M6.15 M 33.51 M Cash from financing activities 94 M67.12 M48.6 M36.72 M139 K 14.18 M Free cash flow 49.35 M53.39 M79.87 M60.16 M24.01 M 33.59 M

ニュース

SCYNEXIS、SCY-247静脈内製剤治験で初の患者への投与を実施

SCYNEXIS doses first patients in SCY-247 IV formulation trial

JERSEY CITY - FDA grants fast track and QIDP designations to SCYNEXIS drug

Scynexisがナスダックから上場要件を満たすための180日間の延長を取得

Scynexis receives 180-day extension from Nasdaq to meet listing requirements

SCYNEXISが抗真菌研究に年間700万ドルの助成金を受領

SCYNEXIS receives $7 million annual grant for antifungal research

グッゲンハイム、GSK試験解決後にSCYNEXISの目標株価を3ドルに引き下げ

Guggenheim lowers SCYNEXIS stock price target to $3 after GSK trial resolution

SCYNEXISがMARIO試験終了に伴いGSKから2200万ドルを受領

SCYNEXIS receives $22 million from GSK as MARIO study ends

Scynexisは新合意に基づきMARIO試験終了でGSKから2430万ドルを受領